Author

Mario Ciocca

National Center for Oncological HadrontherapyORCID 0000-0002-9311-8838Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Angelica FacoettiiD· 1 shared Anthony J. DavisiD· 1 shared Arnold Pompoš· 1 shared Brock J. SishciD· 1 shared Elizabeth M. AlvesiD· 1 shared Huiming LuiD· 1 shared James H. NicholsoniD· 1 shared Janapriya SahaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Angelica FacoettiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer Biologynpj Precision OncologyPeer-reviewedJan 17, 2025

Defective Homologous Recombination and Genomic Instability Predict Increased Responsiveness to Carbon Ion Radiotherapy in Pancreatic Cancer

Brock J. Sishc, Janapriya Saha, Elizabeth M. Alves…·Anthony J. Davis

This study identifies PDAC cell lines defective in homologous recombination or with high genomic instability as more responsive to carbon ion radiotherapy, suggesting potential for targeted therapy.

10 citations

humanbulk RNA-seq

𝕏 PostBluesky